ANTHONY AMAGWU: Open Payments
NPI 1710159058 · CENTERVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 20 payments from 13 companies in 2025. Trend: 2023 $1,028 · 2024 $933 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $94 |
| Laborie Medical Technologies Corp. | 3 | $55 |
| Merck Sharp & Dohme LLC | 1 | $34 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $34 |
| Caris MPI, Inc. | 1 | $29 |
| UROGEN PHARMA, INC. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| PFIZER INC. | 1 | $19 |
| Endo USA, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
Products named: ORGOVYX, GEMTESA, XTANDI, KEYTRUDA, MI CANCER SEEK, EndoSheath Technology, JELMYTO, Nubeqa.
Industry payments across OH — which companies pay providers there.
